ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Why Beckley Psytech is Developing the Next Generation of Psychedelics"
Episode Synopsis
In this episode, Brandon Li sits down with Cosmo Feilding-Mellen, CEO of Beckley Psytech, to explore the groundbreaking work Beckley is doing in the world of psychedelics. Cosmo shares his journey growing up in a family immersed in psychedelic research, co-founding Beckley Psytech, and pushing the boundaries of mental health treatment with next-generation compounds like 5-MeO-DMT.
Tune in to discover why Beckley Psytech is focusing on shorter, scalable psychedelic treatments for conditions like treatment-resistant depression and substance use disorders. Cosmo explains how their innovative approach aims to make these therapies more accessible while maintaining high ethical standards, balancing cutting-edge science with compassionate care. Learn about the future of psychedelics as pharmaceutical medicines, and what it takes to develop new treatments in this rapidly evolving field.
Tune in to discover why Beckley Psytech is focusing on shorter, scalable psychedelic treatments for conditions like treatment-resistant depression and substance use disorders. Cosmo explains how their innovative approach aims to make these therapies more accessible while maintaining high ethical standards, balancing cutting-edge science with compassionate care. Learn about the future of psychedelics as pharmaceutical medicines, and what it takes to develop new treatments in this rapidly evolving field.
More episodes of the podcast Power to the Patients
Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan
21/10/2025
Dr. Anantha Shekhar on the Convergence of Psychiatry, Neurology, and the Next Era of Brain Medicine
15/10/2025
In God we trust